Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$31.53 - $35.26 $9,459 - $10,578
-300 Reduced 42.86%
400 $13,000
Q1 2024

May 15, 2024

BUY
$31.51 - $38.69 $6,302 - $7,738
200 Added 40.0%
700 $25,000
Q4 2023

Feb 14, 2024

SELL
$23.51 - $33.51 $2,351 - $3,351
-100 Reduced 16.67%
500 $16,000
Q3 2023

Nov 14, 2023

SELL
$26.83 - $32.52 $206,591 - $250,404
-7,700 Reduced 92.77%
600 $16,000
Q2 2023

Aug 14, 2023

BUY
$26.64 - $33.63 $23,976 - $30,267
900 Added 12.16%
8,300 $261,000
Q1 2023

May 15, 2023

BUY
$26.45 - $33.0 $190,440 - $237,600
7,200 Added 3600.0%
7,400 $201,000
Q4 2022

Feb 14, 2023

BUY
$28.38 - $31.77 $5,676 - $6,354
200 New
200 $6,000

Others Institutions Holding SBIO

About ALPS ETF TR MEDICAL BREAKTHROU


  • Ticker SBIO
  • Sector ETFs
  • Industry ETFs
More about SBIO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.